Salicylic Acid in Psoriasis Treatment

Primary Role: Adjunctive Therapy, Not Monotherapy

Salicylic acid lacks placebo-controlled evidence supporting its use as monotherapy for psoriasis, with limited data on efficacy when used alone 1, 3
The mechanism of salicylic acid works by reducing keratinocyte-to-keratinocyte binding and lowering stratum corneum pH, leading to reduced scaling and softening of psoriatic plaques 1, 3

The American Academy of Dermatology recommends that salicylic acid combined with topical corticosteroids can be used for moderate to severe psoriasis (BSA ≤20%) 2, 4
Mometasone furoate 0.1% plus salicylic acid 5% was significantly more effective than mometasone alone in 408 patients with moderate-to-severe psoriasis, showing superior improvement in erythema, induration, and scaling beginning at day 8 of treatment 1, 2
Salicylic acid's keratolytic effects increase skin penetration of other topical agents, enhancing the efficacy of combination therapy 1, 5

Do not apply salicylic acid to more than 20% of body surface area due to risk of systemic salicylate toxicity 1, 3, 5
Never combine topical salicylic acid with oral salicylate drugs (aspirin, NSAIDs) due to additive systemic effects 1, 3, 5
Salicylic acid decreases UVB phototherapy efficacy due to a filtering effect—do not apply before UVB treatment 1, 3, 5

Pregnancy: Salicylic acid appears safe for localized psoriasis control when applied to limited areas 1, 3, 5
Pediatrics: Salicylic acid should be avoided in children due to greater risk of systemic absorption and toxicity from higher body-surface-to-mass ratio 1, 3, 5